Literature DB >> 11696376

Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene.

T Yoshida1, A Maeda, N Tani, T Sakai.   

Abstract

The death receptor 5 (DR5) is a receptor for tumor necrosis factor-related apoptosis-inducing ligand and is able to induce apoptosis in various tumor cells. The expression of DR5 is up-regulated at the transcriptional level by p53, genotoxic stress and so on. To investigate the structure of the DR5 gene promoter, we screened and sequenced a genomic clone containing the 5'-flanking region of the DR5 gene. RNase protection assays showed two major transcription start sites around -122 and -137 upstream of the translation initiation codon ATG. Transient transfections with serial 5'-deletion mutants identified the minimal promoter element spanning -198 to -116. Site-directed mutagenesis demonstrated that the DR5 gene promoter has no typical TATA-box, but has two Sp1 sites responsible for the basal transcription activity of the DR5 gene promoter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696376     DOI: 10.1016/s0014-5793(01)02947-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

Review 1.  Resistance to TRAIL and how to surmount it.

Authors:  Danijela Maksimovic-Ivanic; Stanislava Stosic-Grujicic; Ferdinando Nicoletti; Sanja Mijatovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.

Authors:  Shashirekha Shetty; Bonnie A Graham; Jennifer G Brown; Xiaojie Hu; Nicolette Vegh-Yarema; Gary Harding; James T Paul; Spencer B Gibson
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  TRAIL-induced apoptosis is enhanced by heat shock protein 70 expression.

Authors:  N J Clemons; R L Anderson
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

4.  High-level Sp1 is Associated with Proliferation, Invasion, and Poor Prognosis in Astrocytoma.

Authors:  Yi-Ting Chen; Hung-Pei Tsai; Chun-Chieh Wu; Chiao-Yun Chen; Chee-Yin Chai; Aij-Lie Kwan
Journal:  Pathol Oncol Res       Date:  2018-06-09       Impact factor: 3.201

Review 5.  Combined modality therapy with TRAIL or agonistic death receptor antibodies.

Authors:  Hope M Amm; Patsy G Oliver; Choo Hyung Lee; Yufeng Li; Donald J Buchsbaum
Journal:  Cancer Biol Ther       Date:  2011-03-01       Impact factor: 4.742

6.  Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression.

Authors:  Jie Ding; Gernot Polier; Rebecca Köhler; Marco Giaisi; Peter H Krammer; Min Li-Weber
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

7.  Cardamonin sensitizes tumour cells to TRAIL through ROS- and CHOP-mediated up-regulation of death receptors and down-regulation of survival proteins.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

8.  Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation.

Authors:  In Young Kim; You Jung Kang; Mi Jin Yoon; Eun Hee Kim; Seung U Kim; Taeg Kyu Kwon; In Ah Kim; Kyeong Sook Choi
Journal:  Neuro Oncol       Date:  2011-02-03       Impact factor: 12.300

9.  Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells.

Authors:  Stavroula Baritaki; Eriko Suzuki; Kazuo Umezawa; Demetrios A Spandidos; James Berenson; Tracy R Daniels; Manuel L Penichet; Ali R Jazirehi; Michael Palladino; Benjamin Bonavida
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

10.  Poly(ADP-ribose) polymerase inhibitors sensitize cancer cells to death receptor-mediated apoptosis by enhancing death receptor expression.

Authors:  X Wei Meng; Brian D Koh; Jin-San Zhang; Karen S Flatten; Paula A Schneider; Daniel D Billadeau; Allan D Hess; B Douglas Smith; Judith E Karp; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.